← Browse by Condition
Medical Condition

follicular lymphoma grade 3b

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT05377307
Recruiting

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Enrollment
49 pts
Location
Taiwan
Sponsor
Pell Bio-Med Technology Co., L...
View Trial →